Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Antiepileptic Drugs: Sodium Channel Blockers01:08

Antiepileptic Drugs: Sodium Channel Blockers

Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Antiepileptic Drugs: Calcium Channel Blockers01:17

Antiepileptic Drugs: Calcium Channel Blockers

Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Antiepileptic Drugs: Glutamate Antagonists01:14

Antiepileptic Drugs: Glutamate Antagonists

Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dorso-Ventral and Night-Day Regulation of Extracellular K<sup>+</sup> Dynamics in Mouse Hippocampal Astrocytes.

Glia·2026
Same author

AI-Generated Scientific Papers: Crisis? What Crisis?

eNeuro·2026
Same author

Timing is everything: Expert opinion on researching epilepsy rhythms by the ILAE Task Force on Chronobiology.

Epilepsia·2026
Same author

The accumulation of extracellular K<sup>+</sup> as in vivo model of epilepsy in CA1 pyramidal neurons.

Scientific reports·2025
Same author

BDNF exerts an NRF2-dependent cytoprotective function via a receptor-independent pathway.

Cell reports·2025
Same author

Chronoepileptology: Mapping the Rhythms of Seizure Risk.

Epilepsy currents·2025

Related Experiment Video

Updated: May 16, 2026

Microdialysis of Excitatory Amino Acids During EEG Recordings in Freely Moving Rats
08:47

Microdialysis of Excitatory Amino Acids During EEG Recordings in Freely Moving Rats

Published on: November 8, 2018

Treating epilepsy with a light potassium diet.

Christophe Bernard1

  • 1Aix Marseille Université, INS, and Inserm, UMRS 1106, Marseille Cedex 05, France. christophe.bernard@univ-amu.fr

Science Translational Medicine
|November 24, 2012
PubMed
Summary
This summary is machine-generated.

Gene therapy successfully reduced neuron excitability in a rat epilepsy model. This approach prevented seizure development and stopped ongoing epileptic activity.

More Related Videos

Electrophoretic Delivery of &#x3B3;-aminobutyric Acid (GABA) into Epileptic Focus Prevents Seizures in Mice
07:01

Electrophoretic Delivery of γ-aminobutyric Acid (GABA) into Epileptic Focus Prevents Seizures in Mice

Published on: May 16, 2019

Making, Testing, and Using Potassium Ion Selective Microelectrodes in Tissue Slices of Adult Brain
11:20

Making, Testing, and Using Potassium Ion Selective Microelectrodes in Tissue Slices of Adult Brain

Published on: May 7, 2018

Related Experiment Videos

Last Updated: May 16, 2026

Microdialysis of Excitatory Amino Acids During EEG Recordings in Freely Moving Rats
08:47

Microdialysis of Excitatory Amino Acids During EEG Recordings in Freely Moving Rats

Published on: November 8, 2018

Electrophoretic Delivery of &#x3B3;-aminobutyric Acid (GABA) into Epileptic Focus Prevents Seizures in Mice
07:01

Electrophoretic Delivery of γ-aminobutyric Acid (GABA) into Epileptic Focus Prevents Seizures in Mice

Published on: May 16, 2019

Making, Testing, and Using Potassium Ion Selective Microelectrodes in Tissue Slices of Adult Brain
11:20

Making, Testing, and Using Potassium Ion Selective Microelectrodes in Tissue Slices of Adult Brain

Published on: May 7, 2018

Area of Science:

  • Neuroscience
  • Genetics
  • Epilepsy Research

Background:

  • Focal neocortical epilepsy is a debilitating neurological disorder characterized by recurrent seizures originating in a specific brain region.
  • Current treatments for epilepsy have limitations and do not offer a cure for all patients.

Purpose of the Study:

  • To investigate the efficacy of gene therapy in a rat model of focal neocortical epilepsy.
  • To determine if gene therapy can reduce neuronal excitability and prevent seizure activity.

Main Methods:

  • Utilized a rat model of focal neocortical epilepsy.
  • Administered gene therapy to target affected brain regions.
  • Assessed changes in neuron excitability and epileptic activity.

Main Results:

  • Gene therapy significantly decreased neuron excitability in the affected cortical areas.
  • The treatment effectively prevented the development of epileptogenesis (the process by which epilepsy develops).
  • Gene therapy abrogated (stopped) ongoing epileptic activity in the model.

Conclusions:

  • Gene therapy shows promise as a novel therapeutic strategy for focal neocortical epilepsy.
  • Targeting neuron excitability via gene therapy can effectively control and prevent seizures.
  • This preclinical study provides a strong foundation for further development of gene therapy for epilepsy.